AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 145 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $300,000 | -22.9% | 39,988 | -6.4% | 0.09% | -9.6% |
Q1 2022 | $389,000 | +67.7% | 42,732 | +29.1% | 0.10% | +79.3% |
Q4 2021 | $232,000 | -45.2% | 33,089 | -10.8% | 0.06% | -47.3% |
Q3 2021 | $423,000 | -10.0% | 37,086 | +26.4% | 0.11% | -9.1% |
Q2 2021 | $470,000 | -12.8% | 29,334 | -2.7% | 0.12% | -19.3% |
Q1 2021 | $539,000 | -5.8% | 30,155 | -28.8% | 0.15% | -10.2% |
Q4 2020 | $572,000 | +26.8% | 42,358 | +10.5% | 0.17% | +10.6% |
Q3 2020 | $451,000 | +20.6% | 38,339 | +51.2% | 0.15% | +8.6% |
Q2 2020 | $374,000 | +154.4% | 25,361 | +133.1% | 0.14% | +113.8% |
Q1 2020 | $147,000 | – | 10,881 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 906,317 | $16,078,000 | 4.88% |
Asymmetry Capital Management, L.P. | 85,834 | $1,523,000 | 3.39% |
March Altus Capital Management LP | 30,962 | $549,000 | 3.23% |
DAFNA Capital Management LLC | 165,669 | $2,939,000 | 2.92% |
Partner Investment Management, L.P. | 49,726 | $882,000 | 1.33% |
Boulegeris Investments, Inc. | 93,320 | $1,655,000 | 1.27% |
PFM Health Sciences, LP | 2,218,198 | $39,351,000 | 1.11% |
NORTHPOINTE CAPITAL LLC | 443,125 | $7,861,000 | 1.02% |
HARVEY CAPITAL MANAGEMENT INC | 121,850 | $2,161,000 | 0.86% |
Granite Point Capital Management, L.P. | 70,000 | $1,242,000 | 0.85% |